Life Sciences 2012-11-01

Clioquinol-induced increase and decrease in the intracellular Zn2+ level in rat thymocytes.

TomohiroM Oyama, Shiro Ishida, Yoshiro Okano, Hakaru Seo, Yasuo Oyama

Index: Life Sci. 91(23-24) , 1216-20, (2012)

Full Text: HTML

Abstract

Clioquinol is emerging as a potential therapy for some diseases, such as Alzheimer disease and cancer. This agent is a lipophilic chelator of Zn(2+). In this study, the effect of clioquinol on the intracellular Zn(2+) level was examined in order to gain insights into the toxicological profile of clioquinol.

Related Compounds

Related Articles:

Investigation of a Degradant in a Biologics Formulation Buffer Containing L-Histidine.

2015-08-01

[Pharm. Res. 32 , 2625-35, (2015)]

Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime).

2014-01-01

[Nucl. Med. Biol. 41(10) , 813-24, (2014)]

Dicarbonyl Induced Structural Perturbations Make Histone H1 Highly Immunogenic and Generate an Auto-Immune Response in Cancer.

2015-01-01

[PLoS ONE 10 , e0136197, (2015)]

A family of cationic polyamides for in vitro and in vivo gene transfection.

2015-08-01

[Acta Biomater. 22 , 120-30, (2015)]

Different mechanisms are involved in oxidative DNA damage and genotoxicity induction by ZnO and TiO2 nanoparticles in human colon carcinoma cells.

2015-10-01

[Toxicol. In Vitro 29 , 1503-12, (2015)]

More Articles...